prikaz prve stranice dokumenta Toxic epidermal necrolysis associated with carvedilol treatment
No public access
Scientific paper - Case study
Toxic epidermal necrolysis associated with carvedilol treatment
Int. Journal of Clinical Pharmacology and Therapeutics, 48 (2010), 08; 549-551. https://doi.org/10.5414/CPP48549
Vlahović-Palčevski, Vera; Milić, Sandra; Hauser, Goran; Protic, Alen; Župan, Željko .; Reljic, M.; Štimac, Davor

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Vlahović Palčevski, V., Milić, S., Hauser, G., Protic, A., Župan, Ž. .., Reljic, M. & Štimac, D. (2010). Toxic epidermal necrolysis associated with carvedilol treatment. Int. Journal of Clinical Pharmacology and Therapeutics, 48. (08), 549-551. doi: 10.5414/CPP48549

Vlahović Palčevski, Vera, et al. "Toxic epidermal necrolysis associated with carvedilol treatment." Int. Journal of Clinical Pharmacology and Therapeutics, vol. 48, no. 08, 2010, pp. 549-551. https://doi.org/10.5414/CPP48549

Vlahović Palčevski, Vera, Sandra Milić, Goran Hauser, Alen Protic, Željko . Župan, M. Reljic and Davor Štimac. "Toxic epidermal necrolysis associated with carvedilol treatment." Int. Journal of Clinical Pharmacology and Therapeutics 48, no. 08 (2010): 549-551. https://doi.org/10.5414/CPP48549

Vlahović Palčevski, V., et al. (2010) 'Toxic epidermal necrolysis associated with carvedilol treatment', Int. Journal of Clinical Pharmacology and Therapeutics, 48(08), pp. 549-551. doi: 10.5414/CPP48549

Vlahović Palčevski V, Milić S, Hauser G, Protic A, Župan Ž., Reljic M, and sur.. Toxic epidermal necrolysis associated with carvedilol treatment. Int. Journal of Clinical Pharmacology and Therapeutics [Internet]. 2010 August 01 [cited 2024 April 25];48(08):549-551. doi: 10.5414/CPP48549

V. Vlahović Palčevski, et al., "Toxic epidermal necrolysis associated with carvedilol treatment", Int. Journal of Clinical Pharmacology and Therapeutics, vol. 48, no. 08, pp. 549-551, August 2010. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:829107. [Accessed: 25 April 2024]

Metadata
Title (english)Toxic epidermal necrolysis associated with carvedilol treatment
AuthorVera Vlahović-Palčevski
AuthorSandra Milić
AuthorGoran Hauser
AuthorAlen Protic
AuthorŽeljko . Župan
AuthorM. Reljic
AuthorDavor Štimac
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pharmacology)
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Objective: To report a case of fatal toxic epidermal necrolysis associated with carvedilol treatment. Case summary: Two days after the initiation of carvedilol treatment, a 70-year old woman presented with skin eruptions in the form of maculous rash with blisters that rapidly progressed to epidermal necrolysis. Although the suspected drug was withdrawn, the reaction was extremely rapid in its development with fatal outcome. Discussion: Carvedilol is not a drug commonly associated with TEN. To our knowledge there are no cases of carvedilol related TEN reported in the literature. Conclusion: Because of the close temporal relationship between the initiation of carvedilol treatment and the appearance of skin eruptions, and because carvedilol was the only new medication the patient had taken, the etiology of TEN was most likely a reaction to this drug. Physicians should be aware of this extremely rare but serious ADR.
Keywords (english)
Languageenglish
Publication typeScientific paper - Case study
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleInt. Journal of Clinical Pharmacology and Therapeutics
Numberingvol. 48, no. 08, pp. 549-551
p-ISSN0946-1965
DOIhttps://doi.org/10.5414/CPP48549
URN:NBNurn:nbn:hr:184:829107
Publication2010-08-01
Document URLhttp://www.dustri.com/article_response_page.html?artId=7780&doi=10.5414/CPP48549&L=0
Type of resourceText
Access conditionsClosed access
Terms of useLicence In copyright icon
Created on2022-09-19 12:37:50